Literature DB >> 26617228

Mechanisms of Aeroallergen Immunotherapy: Subcutaneous Immunotherapy and Sublingual Immunotherapy.

Cevdet Ozdemir1, Umut Can Kucuksezer2, Mübeccel Akdis3, Cezmi A Akdis4.   

Abstract

Allergen immunotherapy (AIT) is an effective way to treat allergic disorders, targeting the underlying mechanisms and altering the disease course by inducing a long-lasting clinical and immune tolerance to allergens. Although sublingual and subcutaneous routes are used in daily practice, many novel ways to decrease side effects and duration and increase efficacy have been pursued. Further studies are needed to develop biomarkers for the identification of AIT responder patients and also to use the developed knowledge in allergy prevention studies. Future directions in AIT include treatments for autoimmune diseases, chronic infections, organ transplantation, and breaking immune tolerance to cancer cells.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allergens; Allergy; Immunotherapy; T regulatory cells; Tolerance

Mesh:

Substances:

Year:  2016        PMID: 26617228     DOI: 10.1016/j.iac.2015.08.003

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  9 in total

1.  Single-allergen sublingual immunotherapy versus multi-allergen subcutaneous immunotherapy for children with allergic rhinitis.

Authors:  Zhong-Xi Wang; Han Shi
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-06-06

2.  Evaluation of nasal fluid β-defensin 2 levels in children with allergic rhinitis.

Authors:  Fatih Dilek; Özkaya Emin; Bilge Gültepe; Mebrure Yazıcı; Erkan Çakır; Ahmet Hakan Gedik
Journal:  Turk Pediatri Ars       Date:  2017-06-01

3.  Patching it together: epicutaneous vaccination with heat-labile Escherichia coli toxin against birch pollen allergy.

Authors:  S S Killingbeck; M Q Ge; A Haczku
Journal:  Allergy       Date:  2017-01       Impact factor: 13.146

4.  Effect of Japanese Cedar Pollen Sublingual Immunotherapy on Asthma Patients with Seasonal Allergic Rhinitis Caused by Japanese Cedar Pollen.

Authors:  Shoko Ueda; Jun Ito; Norihiro Harada; Sonoko Harada; Hitoshi Sasano; Yuuki Sandhu; Yuki Tanabe; Sumiko Abe; Satomi Shiota; Yuzo Kodama; Tetsutaro Nagaoka; Fumihiko Makino; Asako Chiba; Hisaya Akiba; Ryo Atsuta; Sachiko Miyake; Kazuhisa Takahashi
Journal:  Biomolecules       Date:  2022-03-29

Review 5.  Is Allergen Immunotherapy in Children Disease Modifying? A Review of the Evidence.

Authors:  Amanda K Rudman Spergel; Michael Minnicozzi; Lisa M Wheatley; Alkis Togias
Journal:  Curr Allergy Asthma Rep       Date:  2018-07-11       Impact factor: 4.806

6.  Effect of adjuvanted and standard sublingual immunotherapy on respiratory function in pure rhinitis due to house dust mite over a 5-year period.

Authors:  Maurizio Marogna; Alessandro Massolo; Giovanni Passalacqua
Journal:  World Allergy Organ J       Date:  2017-02-14       Impact factor: 4.084

Review 7.  Allergic diseases in the elderly: biological characteristics and main immunological and non-immunological mechanisms.

Authors:  Maria Teresa Ventura; Nicola Scichilone; Roberto Paganelli; Paola Lucia Minciullo; Vincenzo Patella; Matteo Bonini; Giovanni Passalacqua; Carlo Lombardi; Livio Simioni; Erminia Ridolo; Stefano R Del Giacco; Sebastiano Gangemi; Giorgio Walter Canonica
Journal:  Clin Mol Allergy       Date:  2017-02-03

8.  Efficacy of subcutaneous allergen immunotherapy in atopic dogs: A retrospective study of 664 cases.

Authors:  Evelien E M Fennis; Catharina M M van Damme; Yvette M Schlotter; Jacqueline D Sinke; Mieke H G Leistra; Richard T Bartels; Femke Broere
Journal:  Vet Dermatol       Date:  2022-05-30       Impact factor: 1.867

Review 9.  Therapeutic interventions in severe asthma.

Authors:  Giorgio Walter Canonica; Gianenrico Senna; Patrick D Mitchell; Paul M O'Byrne; Giovanni Passalacqua; Gilda Varricchi
Journal:  World Allergy Organ J       Date:  2016-11-28       Impact factor: 4.084

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.